Natpar (parathyroid hormone) 100 micrograms/dose powder and solvent for solution for injection: expected shortage from June 30th, 2022
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Natpar
|
| Active substance |
parathyroid hormone
|
| Therapeutic area (MeSH) |
Hypoparathyroidism
|
| Procedure number |
EMEA/H/C/003861
|
| Regulatory outcome |
Maintenance
|
| DHPC type |
Medicine shortage
|
| Human ATC code |
H05AA03
|
| Dissemination date |
29/04/2022
|